Summary:
Click image to enlargeThis clinical trial is evaluating the safety and effectiveness of an investigational long-acting insulin taken weekly compared to an approved long-acting daily insulin in adults with type 2 diabetes who have never taken insulin before.
Qualified Participants Must:
• Be 18 years of age or older
• Have a diagnosis of type 2 diabetes
• Have taken at least 1 medicine to treat diabetes for the past 3 months
• Never been prescribed insulin before
• Additional criteria apply
Qualified Participants May Receive:
Up to $1850 compensation for time and effort; Investigational medication or approved medication; Study-related medical supplies, blood tests and medical evaluations under the care of a physician.